EGFR Resisters is comprised of over 825 members from 26 countries. They work to increase the size of our EGFR Resisters community with the assistance of advocacy groups and medical professionals. Their aim is to use the strength of our collaboration to drive important research questions and fund novel research and clinical trials.
GO2 Foundation for Lung Cancer transforms survivorship as the world’s leading organization dedicated to saving, extending, and improving the lives of those vulnerable, at risk, and diagnosed with lung cancer. We work to change the reality of living with lung cancer by ending stigma, increasing public and private research funding, and ensuring access to care.
LUNGevity Foundation is firmly committed to making an immediate impact on increasing quality of life and survivorship of people with lung cancer by accelerating research into early detection and more effective treatments, as well as providing community, support, and education for all those affected by the disease. Our vision is a world where no one dies of lung cancer.
The Lung Cancer Research Foundation (LCRF) is the pre-eminent nonprofit organization focused on funding innovative, high-reward research with the potential to extend survival and improve quality of life for people with lung cancer. LCRF’s mission is to improve lung cancer outcomes by funding research for the prevention, diagnosis, treatment and cure of lung cancer. To date, LCRF has funded 362 research grants, totaling nearly $33 million, the highest amount provided by a nonprofit organization dedicated to funding lung cancer research. The Lung Cancer Research Foundation also hosts community events across the country through the Free to Breathe Events Program.
The ROS1ders is a global group of patients and caregivers dealing with ROS1+ cancer. They strive to better outcomes for all ROS1+ cancers by supporting patients and caregivers, increasing awareness and education, accelerating research, and improving access to effective diagnosis and treatment.
